Discover groundbreaking biomedical discoveries, pioneering health care innovations, and expert perspectives from Penn Medicine.
Getting Luka Krizanac new hands took 16 years, a connection between a surgeon and his mentor, and surgeries on two continents.
A $50 million gift from the Lurie family to Children’s Hospital of Philadelphia and Penn Medicine will launch the Lurie Autism Institute to drive autism research.
A Lancaster General Health nurse’s selfless uterus donation transformed a woman’s dream of motherhood. Meet Sara, Emma, and baby Olivia in a story of science and generosity.
The fight against antibiotic resistance has potential new allies: snake, scorpion and spider venom, sourced with the help of AI.
The successes of CAR T research show the importance of the cycle of science—sparking new ideas and clinical trials that give patients better options.
The Penn Medicine Co-Investment program spurs faculty innovation, creates jobs, and helps scale up ideas into large-scale clinical studies.
Public investments in biomedical research have an outsized effect, driving new scientific insights, economic growth, and ultimately treatments and cures.
Nearly two decades into her tenure at Penn, Raina Merchant, MD, leads teams transforming health care for better patient, clinician, and community experiences.
Nancy A. Speck, PhD, has been named the 2025 recipient of the E. Donnall Thomas Lecture and Prize from the American Society of Hematology (ASH).
The DSM, the diagnostic bible of psychiatrists may be improved with new technologies and information. Maria Oquendo, MD, PhD, is leading the team charged with rethinking it.
A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing brain cancer.
In a historic medical breakthrough, a child with a rare genetic disorder has been successfully treated with a customized CRISPR gene editing therapy.
Penn Medicine research is bringing the “sleeper” phase of cancer to light—creating hope that more cancers could be wiped out for good and never come back.
At the unveiling of a refurbished basketball court, Penn Medicine and the 76ers announced a $144,000 donation to grassroots organizations.
For five years, Penn Medicine’s Social Needs Response Team has connected patients to vital support foundational to good health.
To address the xylazine crisis in Philadelphia, Penn Medicine employees are offering support within the health system and in the community.
At Penn Medicine, health care is about the architecture of care for entire communities where people can access treatment when and where they need it.
Uterus transplant is still a rare procedure—but for the six moms who have had eight babies to date through Penn’s program, it means the world.
A joint program from Independence Blue Cross (IBX) and Penn Medicine reimagines the prior-approval process of certain imaging tests.
Men are less likely to have autoimmune diseases. That's likely, at least partially, due to women's two X chromosomes vs. men’s one, says Brian Capell, MD, PhD, a Penn dermatologist who researches sex differences in cancer and autoimmune disease. | June 16, 2025
With a $25 million gift, Penn and CHOP launched a new center to treat and research Williams Syndrome. The genetic condition causes physical and cognitive effects. | July 2, 2025
Research shows the threat of antimicrobial resistance to cancer patients. Infections are the second leading cause of death in cancer patients. Oncologist Yehoda Martei, MD, says there's a greater need to acknowledge this connection globally. | June 26, 2025
Subscribe to Penn Medicine newsletters and publications for the latest developments.
